Tagrisso 80 mg Tablet

Tagrisso 80 mg Tablet contains Osimertinib, a third-generation EGFR inhibitor used in the treatment of advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC).

Uses:

✔ EGFR-Mutated NSCLC – First-line treatment for locally advanced or metastatic lung cancer.
✔ Post-Surgery Therapy – Used in adjuvant therapy to prevent cancer recurrence.
✔ Brain Metastases Treatment – Effectively crosses the blood-brain barrier to treat brain metastases.

How Tagrisso Works:

Osimertinib blocks the activity of mutated epidermal growth factor receptor (EGFR), inhibiting tumor growth and preventing the spread of cancer cells. It is especially effective against T790M resistance mutations.

Common Side Effects:

🔹 Diarrhea
🔹 Skin rash
🔹 Nail changes
🔹 Fatigue
🔹 Decreased appetite

Serious Side Effects (Seek Medical Help):

⚠️ Lung inflammation (interstitial lung disease)
⚠️ Heart problems (irregular heartbeat, heart failure)
⚠️ Severe skin reactions (blisters, peeling)
⚠️ Liver toxicity (yellowing of skin/eyes, dark urine)

Precautions:

⚡ Heart Monitoring Required – Patients with heart conditions need regular ECG checks.
⚡ Pregnancy & Breastfeeding – Not safe for pregnant women; effective contraception required.
⚡ Liver & Kidney Function Tests – Regular monitoring is advised.
⚡ Avoid Grapefruit & St. John’s Wort – Can affect drug absorption and effectiveness.

FAQs:

1. How should I take Tagrisso 80 mg Tablet?
   Take once daily, with or without food, as prescribed by your doctor.

2. Can I stop taking Tagrisso if I feel better?
   No, complete the full course of treatment as directed by your doctor.

3. How long does it take for Tagrisso to work?
   Some patients may notice improvement within a few weeks, but full effects take longer.

4. Does Tagrisso cure lung cancer?
   It does not cure but significantly extends survival and slows progression.

5. Where can I buy Tagrisso 80 mg Tablet online?
   Order from Milan Medicals for authentic medicines, best prices, and worldwide shipping.

References:

🔗 https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208065s021lbl.pdf
🔗 https://www.medicines.org.uk/emc/product/7615/pil